The Latest Womens Health Industry Statistics Explained
Women’s health market size was valued at $32.4 billion in 2019.
The statistic that the women’s health market size was valued at $32.4 billion in 2019 indicates the total monetary value of goods and services related to women’s healthcare during that year. This figure encompasses spending on a wide range of products and services such as medications, medical devices, diagnostic tests, treatment procedures, and healthcare services specifically targeting women’s health needs. The market size provides insight into the economic significance of the women’s health sector, highlighting the substantial investments made in promoting and enhancing women’s well-being and addressing their unique healthcare concerns. This statistic reflects both the demand for women-focused health solutions and the industry’s contribution to the overall healthcare market.
The global women’s health market is expected to reach $41.5 billion by 2025.
This statistic indicates that the total market value for women’s health products and services worldwide is projected to grow to $41.5 billion by the year 2025. This growth reflects an increasing demand for healthcare products and services specifically targeted towards women’s health needs, driven by factors such as an aging population, rising prevalence of chronic diseases, and greater awareness and access to healthcare services among women. The projected growth in the global women’s health market signifies a significant opportunity for businesses and healthcare providers to address the diverse and evolving healthcare needs of women globally, through the development of innovative treatments, preventive care services, and healthcare interventions.
The North American women’s health market held around 44% of total industry revenue in 2019.
The statistic “The North American women’s health market held around 44% of total industry revenue in 2019” indicates that within the women’s health sector, which encompasses various products and services related to women’s well-being and healthcare, North America accounted for almost half of the total revenue generated in 2019. This suggests that the region plays a significant role in the women’s health market globally and highlights the economic importance of addressing women’s health needs in North America. The statistic also implies that there are substantial opportunities for growth, investment, and innovation within the North American women’s health market, making it a key area of focus for healthcare providers, policymakers, and businesses operating in the industry.
Postmenopausal osteoporosis segment of women’s health sector was valued at USD 10 billion in 2019.
This statistic indicates that the market for postmenopausal osteoporosis within the women’s health sector was estimated to be worth USD 10 billion in 2019. Postmenopausal osteoporosis refers to a condition where women are at an increased risk of bone fractures due to decreased bone density after menopause. The USD 10 billion value reflects the total revenue generated from products, services, and treatments specific to managing osteoporosis in postmenopausal women. This statistic highlights the economic significance and potential growth opportunities within the women’s health sector, specifically focusing on addressing the healthcare needs of women post-menopause to prevent and manage osteoporosis-related complications.
The U.S. market for women’s health therapeutics is expected to reach $28 billion by 2023.
The statistic that the U.S. market for women’s health therapeutics is projected to reach $28 billion by 2023 indicates a significant growth opportunity in the industry. This figure suggests a growing demand for pharmaceutical products and treatments specifically tailored for women’s health conditions. Factors contributing to this expected market expansion may include increasing awareness and focus on women’s health issues, advancements in medical research and technology, as well as shifting demographics such as an aging population. Pharmaceutical companies and healthcare providers may need to adapt their strategies to cater to this growing market segment and explore opportunities for innovation and development in women’s health therapeutics to meet the anticipated demand.
Asia Pacific women’s health market is projected to expand at a 5.4% annual growth rate from 2020 to 2027.
The statistic “Asia Pacific women’s health market is projected to expand at a 5.4% annual growth rate from 2020 to 2027” indicates that the market for women’s health products and services in the Asia Pacific region is expected to steadily increase by 5.4% each year over the specified time period. This growth rate suggests a positive outlook for the women’s health sector in the region, reflecting increasing demand for healthcare services, technologies, and products that cater specifically to women’s needs. The projection implies that there are opportunities for investment and expansion in the Asia Pacific women’s health market, with potential for both economic growth and advancements in female healthcare.
China’s women’s health market is estimated to reach $29 billion in 2024, an increase from $23 billion in 2019.
The statistic indicates that the women’s health market in China is projected to experience significant growth over the five-year period from 2019 to 2024. Specifically, the market size is expected to increase from $23 billion in 2019 to $29 billion in 2024. This suggests a compound annual growth rate (CAGR) over that period. Factors contributing to this growth trend may include rising awareness and demand for women’s health products and services, increasing healthcare expenditure, advancements in medical technology, and favorable government policies supporting women’s health initiatives in China. This promising expansion of the women’s health market signifies potential opportunities for healthcare companies, investors, and stakeholders to tap into this growing sector and cater to the evolving healthcare needs of women in the Chinese market.
1 in 8 women in the United States will develop an invasive form of breast cancer over her lifetime.
The statistic “1 in 8 women in the United States will develop an invasive form of breast cancer over her lifetime” represents the lifetime risk of developing breast cancer for women in the US. This statistic indicates that out of a group of 8 women, statistically, one woman will develop invasive breast cancer at some point in her life. This highlights the significant prevalence and impact of breast cancer on women in the US, underscoring the importance of continued efforts in raising awareness, promoting early detection through screenings, and advancing research for improved treatment options. This statistic serves as a powerful reminder of the importance of proactive measures such as regular breast exams and screenings to detect and address breast cancer in its early stages when treatment is more effective.
The U.S. accounts for the largest share in the women’s health market.
The statistic that the U.S. accounts for the largest share in the women’s health market indicates that the United States holds the highest proportion of market sales or revenue in the specific sector focused on women’s health products and services compared to other countries. This suggests that the U.S. market is significantly dominant and influential in providing healthcare solutions tailored to meet the needs of women, such as reproductive health services, maternity care, breast cancer screenings, and women-specific medications. The statistic implies that the U.S. is likely a key player in driving innovation, research, and investment in women’s health, as well as shaping policies and guidelines in this field.
Global Women’s Health Diagnostics Market was valued at $13.2 billion in 2015.
The statistic indicating that the Global Women’s Health Diagnostics Market was valued at $13.2 billion in 2015 reflects the total monetary worth of the market for diagnostic products and services specific to women’s health on a global scale for that particular year. This figure encompasses the revenue generated from various diagnostic tools, tests, devices, and services aimed at addressing the health needs of women worldwide. The statistic highlights the significant market size and economic activity in the field of women’s health diagnostics, underlining the importance and investment in advancing healthcare for women across different regions and demographics.
The CAGR for Global Women’s Health Diagnostics Market is anticipated to be 7.0% from 2016 to 2022.
The Compound Annual Growth Rate (CAGR) of 7.0% for the Global Women’s Health Diagnostics Market from 2016 to 2022 indicates the average annual growth rate of the market over this period. This statistic suggests that the market is expected to expand steadily at a rate of 7.0% each year, showing promising growth opportunities in the women’s health diagnostics industry. Investors and stakeholders can use this data to assess the market’s potential for investment and strategic decision-making, understanding the projected growth trajectory of the market for the specified timeframe.
The United Nations estimates more than half of the women aged 15 to 49 years worldwide use contraceptives.
The statistic provided by the United Nations indicates that a significant proportion of women of reproductive age globally use contraceptives, with more than half of women aged 15 to 49 years utilizing some form of contraception. This statistic underscores the widespread importance and acceptance of contraceptive methods in enabling women to make informed choices about their reproductive health and family planning. Access to and utilization of contraceptives play a crucial role in reducing unintended pregnancies, promoting maternal and child health, empowering women to pursue education and economic opportunities, and ultimately contributing to overall societal well-being and development.
It is expected that use of Hormonal Contraceptives value will rise with a CAGR of 1.9% during 2021- 2030.
This statistic indicates that the use of Hormonal Contraceptives is projected to increase at a Compound Annual Growth Rate (CAGR) of 1.9% from 2021 to 2030. A CAGR of 1.9% means that on average, the use of Hormonal Contraceptives is anticipated to grow by 1.9% each year over the specified period. This suggests a gradual but consistent rise in the usage of Hormonal Contraceptives over the next decade, reflecting potential trends and changes in factors such as healthcare access, awareness, policies, and demographics that could influence contraceptive choices and usage patterns.
The European women’s health market size was valued at USD 6.3 billion in 2019.
The statistic indicates that the total value of the European women’s health market in terms of revenue was calculated to be USD 6.3 billion in the year 2019. This figure includes the collective sales generated from various products and services related to women’s health, such as medications, medical devices, diagnostic services, and other healthcare offerings tailored specifically for women. The market size reflects the economic importance and demand for women’s health products and services in Europe during the mentioned year, serving as a key indicator for stakeholders such as healthcare companies, policymakers, and investors to understand the dynamics and opportunities within the European women’s health industry.
The global women’s health rehabilitation products market was valued at USD 2.6 billion in 2018.
The statistic indicates that the overall market size for women’s health rehabilitation products reached USD 2.6 billion in the year 2018. This figure represents the total monetary value of the products sold within this specific market segment during that year. The value reflects the demand for and consumption of various healthcare products tailored to women’s health needs, such as devices for pelvic floor therapy, postpartum care, and breast health, among others. The significant market size highlights the importance and growth potential of the women’s health rehabilitation sector, serving as a key indicator for industry stakeholders, healthcare professionals, and policymakers to understand the market dynamics and trends in this particular healthcare domain.
It is predicted that the global women’s health market will grow at a CAGR of 4.9% from 2021 to 2028.
This statistic indicates that the global women’s health market is expected to experience a Compound Annual Growth Rate (CAGR) of 4.9% between the years 2021 and 2028. This implies that the market for women’s health products and services, such as reproductive health, maternal care, breast cancer screening, and menopause management, is projected to expand steadily over this time period. The CAGR represents the year-over-year growth rate that, if sustained, would lead to the stated total growth by the end of the specified period. This forecast suggests increasing demand and investment in women’s health globally, likely driven by factors such as rising awareness of women’s health issues, technological advancements, changing demographics, and evolving healthcare policies and regulations.
The menopause health segment was estimated to account for an over 34% share in terms of revenue in the women’s health market in 2020.
This statistic suggests that the menopause health segment, within the women’s health market, was a significant contributor to total revenue in 2020, accounting for more than one-third (34%) of the market share. This indicates that products, services, or treatments focused on addressing menopause-related issues were in strong demand among consumers, leading to a substantial portion of the revenue generated within the women’s health market. The high market share of the menopause health segment highlights the importance of addressing the health concerns and needs of menopausal women, and underscores the potential opportunities for companies and healthcare providers operating in this market segment.
The market for sexual health improvement products for women expected to exceed USD 40 billion by 2025.
This statistic indicates a significant growth trend in the market for sexual health improvement products aimed at women, projecting that the market size is expected to surpass USD 40 billion by the year 2025. This suggests a growing demand and investment in products and services tailored to enhance women’s sexual health and well-being. Factors contributing to this anticipated expansion may include increasing awareness and acceptance of sexual health issues, advancements in technology and product innovation, as well as evolving societal attitudes towards women’s sexual health. The projected growth in this market highlights a potential opportunity for businesses and healthcare professionals to cater to the increasing demand for women’s sexual wellness products and services.
References
0. – https://www.reports.valuates.com
1. – https://www.www.who.int
2. – https://www.www.alliedmarketresearch.com
3. – https://www.www.pharmexec.com
4. – https://www.www.gminsights.com
5. – https://www.www.grandviewresearch.com
6. – https://www.www.reportsanddata.com
7. – https://www.www.globenewswire.com
8. – https://www.www.visiongain.com
9. – https://www.www.fortunebusinessinsights.com
10. – https://www.www.bccresearch.com
11. – https://www.www.breastcancer.org
